C section News and Research

RSS

Targacept reports net loss of $8.1 million in first quarter 2013

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the first quarter ended March 31, 2013.

7 May 2013

Perrigo net sales increase 18% to $920M in third quarter 2013

Perrigo Company today announced results for its third quarter ended March 30, 2013.Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our performance, as the team delivered all-time record quarterly revenue and adjusted diluted earnings per share.

7 May 2013

Cleveland Clinic receives $2M for research in colorectal surgery

Kenneth M. Garschina and his wife, Sara Story, have pledged $2 million to Cleveland Clinic's Digestive Disease Institute to create an endowed chair for research in colorectal surgery. The donation coincides with the re-dedication of two previously funded endowed chairs.

6 May 2013

Program on Medicine and Religion selects faculty scholars

The University of Chicago Medicine's Program on Medicine and Religion has selected its second round of faculty scholars whose focus will be on the relationship between a physician's spirituality and their ability to deal with the pressures of practicing medicine.

6 May 2013

High levels of collagen in breasts are associated with breast cancer metastasis

Researchers at Washington University School of Medicine in St. Louis have discovered why breast cancer patients with dense breasts are more likely than others to develop aggressive tumors that spread.

6 May 2013

FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a supplemental new drug application for SUSTIVA (efavirenz), including dosing recommendations for HIV-1 infected pediatric patients three months to three years old and weighing at least 3.5 kg.

4 May 2013

Obama 'comfortable' with morning-after pill sales at 15

President Barack Obama said he is "very comfortable" with the Food and Drug Administration rule announced this week to make the so-called morning after pill available without a prescription to women and girls who are at least 15 -- younger than the current limit of 17.

4 May 2013

Cambrex sales increase by 5.7% in first quarter 2013

Cambrex Corporation reports results for the first quarter ended March 31, 2013.

3 May 2013

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

Medical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism.

3 May 2013

Tosoh Bioscience announces GPC glossary and column selection mobile app

Tosoh Bioscience LLC has announced the availability of the GPC Glossary and Column Selection Guide app, which offers easy access to 200 Gel Permeation Chromatography (GPC) terms and a GPC column selection wizard for precise directions to the ideal GPC columns for polymer molar mass distribution characterization.

2 May 2013

MSF, GAVI Alliance vaccine discussion shows complications in global health programs

Writing in the American Public Health Association International Health Section's "IH-Blog," Jessica Keralis, IH Communications Committee chair, highlights three recently released advocacy videos by Médecins Sans Frontières discussing child vaccines and a subsequent conversation between MSF and the GAVI Alliance over vaccine pricing.

2 May 2013

ABA honors Loyola's Burn & Shock Trauma Institute director with President's Leadership Award

Richard L. Gamelli, MD, FACS, senior vice president and provost of the Health Sciences Division at Loyola University Chicago, has been awarded the President's Leadership Award from the American Burn Association.

2 May 2013

UK’s health performance: an interview with Prof. Murray, University of Washington

Rates of premature mortality in the UK have been falling steadily, but the pace of decline is not as fast as in many other high-income countries, such as Australia. In that sense, the UK lags behind.

29 Apr 2013

ABA honors Richard L. Gamelli with President's Leadership Award

Richard L. Gamelli, MD, FACS, senior vice president and provost of the Health Sciences Division at Loyola University Chicago, has been given the President's Leadership Award from the American Burn Association.

29 Apr 2013

A health exchange exemption: Capitol Hill's big headache

Talk around the halls of Congress regarding whether lawmakers and congressional aides will be given an exemption from a part of the health law that requires them to obtain their health coverage from online insurance marketplaces.

29 Apr 2013

First Edition: April 26, 2013

Today's headlines include reports that some Democratic senators have concerns about the health law's roll out as well as other news about the measure's implementation.

26 Apr 2013

New device allows automatic suturing of large intestine during cancer colon surgery

The Spanish research centre Innotex has developed a device that enables automatic suturing of the large intestine after being sectioned during cancer colon surgery. The novelty of the system, called Insewing, is that it allows the use of absorbable suture material instead of metallic staples which are currently used and could cause intestinal stiffness and obstruction.

26 Apr 2013

High-energy proton beam therapy offers potential treatment option for eye cancer

Particle beams - from low energy beams with exotic ions through to extremely high energy light sources - are revolutionising the way we view the world and creating potential for new industries, but the instrumentation for controlling the beams is still in its infancy.

26 Apr 2013

Cempra reports net loss of $10.3 million in first quarter 2013

Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the first quarter ended March 31, 2013.

26 Apr 2013

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

Greatbatch, Inc., today announced results for its first quarter ended March 29, 2013 highlighted by a 19% increase in adjusted diluted EPS despite negative 4% constant currency organic revenue growth.

26 Apr 2013

C section News and Research

Targacept reports net loss of $8.1 million in first quarter 2013

Perrigo net sales increase 18% to $920M in third quarter 2013

Cleveland Clinic receives $2M for research in colorectal surgery

Program on Medicine and Religion selects faculty scholars

High levels of collagen in breasts are associated with breast cancer metastasis

FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

Obama 'comfortable' with morning-after pill sales at 15

Cambrex sales increase by 5.7% in first quarter 2013

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

Tosoh Bioscience announces GPC glossary and column selection mobile app

MSF, GAVI Alliance vaccine discussion shows complications in global health programs

ABA honors Loyola's Burn & Shock Trauma Institute director with President's Leadership Award

UK’s health performance: an interview with Prof. Murray, University of Washington

ABA honors Richard L. Gamelli with President's Leadership Award

A health exchange exemption: Capitol Hill's big headache

First Edition: April 26, 2013

New device allows automatic suturing of large intestine during cancer colon surgery

High-energy proton beam therapy offers potential treatment option for eye cancer

Cempra reports net loss of $10.3 million in first quarter 2013

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News